Patient Outcomes According to Adherence to Treatment Guidelines for Rhythm Control of Atrial Fibrillation

@inproceedings{Qin2015PatientOA,
  title={Patient Outcomes According to Adherence to Treatment Guidelines for Rhythm Control of Atrial Fibrillation},
  author={Dingxin Qin and George Leef and Mian Bilal Alam and Rohit Rattan and Mohamad Bilal Munir and Divyang N. Patel and Furqan Khattak and Nishit Vaghasia and Evan C Adelstein and Sandeep Kumar Jain and Samir Saba},
  booktitle={Journal of the American Heart Association},
  year={2015}
}
BACKGROUND Although guidelines for antiarrhythmic drug therapy in atrial fibrillation (AF) were published in 2006, it remains uncertain whether adherence to these guidelines affects patient outcomes. METHODS AND RESULTS We retrospectively evaluated the records of 5976 consecutive AF patients who were prescribed at least 1 antiarrhythmic drug between 2006 and 2013. Patients with 1 or more prescribed antiarrhythmic drugs that did not comply with guideline recommendations comprised the non… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Classification of antiarrhythmic drugs

VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Effect of dronedarone on cardiovascular events in atrial fi brillation

SH Hohnloser, HJ Crijns, +4 authors SJ Connolly
  • N Engl J Med
  • 2014

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2012